Adiponectin in outpatients with coronary artery disease: Independent predictors and relationship with heart failure

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 22, Issue 3, 2012, Pages 292-299

  Baldasseroni, S ^a   Mannucci, E ^a   Orso, F ^a   Di Serio, C ^a   Pratesi, A ^a   Bartoli, N ^a   Marella, G A ^a   Colombi, C ^a   Foschini, A ^a   Valoti, P ^a   Mossello, E ^a   Fumagalli, S ^a   Marchionni, N ^a   Tarantini, F ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Adiponectin; Coronary artery disease; Heart failure; Metabolism

Indexed keywords

ADIPONECTIN; ADIPOQ PROTEIN, HUMAN; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; AGED; ARTICLE; BLOOD; BODY MASS; CHI SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; ITALY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTPATIENT; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SYSTOLE; UPREGULATION;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BODY MASS INDEX; CHI-SQUARE DISTRIBUTION; CHOLESTEROL, HDL; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FAILURE; HUMANS; ITALY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; OUTPATIENTS; PEPTIDE FRAGMENTS; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SYSTOLE; UP-REGULATION; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84857918280     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2011.03.012     Document Type: Article

References (31)

1. Schrier R.W., Abraham W. Hormones and hemodynamics in heart failure. N Eng J Med 1999, 341:577-585.
2. Itoh K., Osada N., Inoue K., Samejima H., Seki A., Omiya K., et al. Relationship between exercise intolerance and levels of neurohormonal factors and proinflammatory cytokines in patient with stable chronic heart failure. Int Heart J 2005, 46:1049-1059.
3. Ashrafian H., Frenneaux M.P., Opie L.H. Metabolic mechanisms in heart failure. Circulation 2007, 116:434-448.
4. Nakamura T., Funayama H., Kubo N., Yasu T., Kawakami M., Saito M., et al. Association of hyperadiponectinemia with severity of ventricular dysfunction in congestive heart failure. Circ J 2006, 70:1557-1562.
5. Tilg H., Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature 2006, 6:772-783.
6. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999, 100:2473-2476.
7. Nishida M., Funahashi T., Shimomura I. Pathophysiological significance of adiponectin. Med Mol Morphol 2007, 40:55-67.
8. Berg A.H., Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005, 96:939.
9. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004, 291:1730-1737.
10. Kumada M., Kihara S., Sumitsuji S., Kawamoto T., Matsumoto S., Ouchi N., et al. Coronary artery disease. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003, 23:85-89.
11. Ouchi N., Kobayashi H., Kihara S., Kumada M., Sato K., Inoue T., et al. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 2004, 279:1304-1309.
12. Kistorp C., Faber J., Galatius S., Gustafsson F., Frystyk J., Flyvbjerg A., et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005, 112:1756-1762.
13. McEntegart M.B., Awede B., Petrie M.C., Sattar N., Dunn Fg, MacFarlane N.G., et al. Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines and B-type natriuretic peptide. Eur Heart J 2007, 28:829-835.
14. Swedberg K., Cleland J., Dargie H., Drexler H., Follath F., Komajda M., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur Heart J 2005, 26:1115-1140.
15. Di Bari M., Pozzi C., Cavallini M.C., Innocenti F., Baldereschi G., De Alfieri W., et al. The diagnosis of heart failure in the community. Comparative validation of four sets of criteria in unselected older adults: the ICARe Dicomano study. J Am Coll Cardiol 2004, 44:1601-1608.
16. Yesavage J.A., Brink T.L., Rose T.L., Lum O., Huang V., Adey M., et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982, 17:37-49.
17. Greenfield S., Blanco D.M., Elashoff R.M., Ganz P.A. Development and testing of a new index of comorbidity. Clin Res 1987, A35:346.
18. Ruan H., Lodish H.F. Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. Cytokine Growth Factor Rev 2003, 14:447-455.
19. Haugen E., Furukawa Y., Isic A., Fu M. Increased adiponectin level in parallel with increased NT-pro BNP in patients with severe heart failure in the elderly: a hospital cohort study. Int J Cardiol 2008, 125:216-219.
20. Tsutamoto T., Tanaka T., Sakai H., Ishikawa C., Fujii M., Yamamoto T., et al. Total and high molecular weight adiponectin, haemodynamics and mortality in patients with chronic heart failure. Eur Heart J 2007, 28:1723-1730.
21. Kintscher U. Does adiponectin resistance exist in chronic heart failure?. Eur Heart J 2007, 6:12.
22. Van Berendoncks A.M., Garnier A., Beckers P., Hoymans V.Y., Possemiers N., Fortin D., et al. Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure. Circ Heart Fail 2010, 3:185-194.
23. Minotti J.L., Christoph I., Massie B.M. Skeletal muscle function, morphology, and metabolism in patients with congestive heart failure. Chest 1992, 101:333S-339S.
24. Fruebis J., Tsao T.S., Javorschi S., Ebbets-Reed D., Erickson M.R., Yen F.T., et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 2001, 98:2005-2010.
25. Shinmura K., Tamaki K., Saito K., Natano Y., Tobe T., Bolli R. Cardioprotective effects of short-term caloric restriction are mediated by adiponectin via activation of AMP-activated protein kinase. Circulation 2007, 116:2809-2817.
26. Sandek A., Bauditz J., Swidsinski A., Bunher S., Weber-Eibel J., von Haeling S., et al. Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol 2007, 50:1561-1569.
27. Sengenes C., Berlan M., De Glisezinski I., Lafontan M., Galitzky J. Natriuretic peptide: a new lipolytic pathway in human adipocytes. FASEB J 2000, 14:1345-1351.
28. Tsukamoto O., Fujita M., Kato M., Yamazaki S., Asano Y., Ogai A., et al. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. J Am Coll Cardiol 2009, 53:2070-2077.
29. von Eynatten M., Hamann A., Twardella D., Nawroth P.P., Brenner H., Rothenbacher D. Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease. Clin Chem 2006, 52:853-859.
30. Giannessi D., Caselli C., Del Ry S., Maltinti M., Pardini S., Turchi S., et al. Adiponectin is associated with abnormal lipid profile and coronary microvascular dysfunction in patients with dilated cardiomyopathy without overt heart failure. Metabolism 2010, [Epub ahead of print].
31. Van Linthout S., Foryst-Ludwig A., Spillmann F., Peng J., Feng Y., Meloni M., et al. Impact of HDL on adipose tissue metabolism and adiponectin expression. Atherosclerosis 2010, 210:438-444.